RS 25259

Known as: RS-25259

National Institutes of Health

1995-1998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

1999

Is this relevant?

1998

UNLABELLED We evaluated the safety and efficacy of RS-25259, a potent and long-acting selective 5-HT3 receptor antagonist, for… (More)

Is this relevant?

Highly Cited

1995

Highly Cited

1995

1. A series of isoquinolines have been identified as 5-HT3 receptor antagonists. One of these, RS 25259-197 [(3aS)-2-[(S)-1… (More)

Is this relevant?

1995

1. The pharmacological effects in vivo, of RS 25259-197, a selective 5-HT3 receptor antagonist, have been investigated. 2. In… (More)

Is this relevant?